
Portugal · Pharmaceuticals startup
INEYE THERAPEUTICS S.A.
Funding reportedLast round: Seed
Follow INEYE THERAPEUTICS and see its new rounds in your feed.Start following
INEYE THERAPEUTICS S.A.
is a healthcare and life sciences company based in Coimbra, Portugal. The company focuses on enhancing quality of life by preventing blindness and visual impairment through innovative medical devices and pharmaceutical products. Its primary work revolves around ophthalmic drug-delivery technology, particularly the InEye® platform, which releases flurbiprofen and moxifloxacin at controlled rates. INEYE THERAPEUTICS operates as a research and development and product-development company in the field of ophthalmology. It is advancing technologies from development to clinical evaluation and commercialization. The company is engaged in ongoing research and clinical-trial preparation, with a roadmap that includes testing InEye® formulations for specific treatments. Its publicly advertised products include the InEye® ophthalmic delivery system and related drug-device concepts aimed at treating eye diseases. The company collaborates with institutions like ULS Coimbra on various projects.
Funding, as reported
From INEYE THERAPEUTICS's own website: 2 founders, 2 on the team.
AdvisersHelena GilJoaquim Murta
What they build
Known for
medicalpharmaceuticalspharmaceutical manufacturing
Built with from their website
Microsoft ExchangeMicrosoft 365 Apps & ServicesMicrosoft Exchange OnlineMicrosoft 365OutlookMicrosoft Email ProvidersGoogle Search Console
Add your raise, your deck and your story, and put INEYE THERAPEUTICS in front of investors. Or tell us what we have wrong.